NYSCF Scientists One Step Closer to Cell Replacement Therapies for MS

For the first time, NYSCF scientists generated induced pluripotent stem (iPS) cells lines from skin samples of patients with primary progressive multiple sclerosis and further, they developed an accelerated protocol to induce these stem cells into becoming oligodendrocytes, the myelin-forming cells of the central nervous system implicated in multiple sclerosis and many other diseases.

These stem cell lines will allow researchers to “turn back the clock” and observe how multiple sclerosis develops and progresses, potentially revealing the onset of the disease at a cellular level long before any symptoms are displayed. The improved protocol for deriving oligodendrocyte cells will also provide a platform for disease modeling, drug screening, and for replacing the damaged cells in the brain with healthy cells generated using this method.

Read the press release

Read the paper in Stem Cell Reports

This research was also featured in Neurology Today – Read the story

Diseases & Conditions:

Multiple Sclerosis, Neurobiology

People mentioned: